Showing results (591-600 of 649) with videos related to

Sort By:
Pageof 65
Hospital Pediatrics|October 2, 2024
A National Analysis of General Pediatric Inpatient Unit Closures and Openings, 2011-2018Carolyn M San Soucie, Nancy D Beaulieu, Jason D Buxbaum, et al.
Cancer|December 18, 2001
A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188)W J Gradishar, P Stephenson, D J Glover, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2007
Determination of the elimination half-life of fibroblast growth factor-23Azarmindokht Khosravi, Carolee M Cutler, Marilyn H Kelly, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 20, 2005
Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin DMichael T Collins, John R Lindsay, Alka Jain, et al.
Anaesthesia|August 1, 2021
A retrospective audit of postoperative days alive and out of hospital, including before and after implementation of the WHO surgical safety checklistM R Moore, S J Mitchell, J M Weller, et al.
Journal of Pain and Symptom Management|November 6, 1998
The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind studyW C Parris, B W Johnson, M K Croghan, et al.
JAMA Internal Medicine|December 14, 2020
Assessment of Electronic Health Record Use Between US and Non-US Health SystemsA Jay Holmgren, N Lance Downing, David W Bates, et al.
The Journal of Trauma and Acute Care Surgery|April 22, 2017
Potential impact of Affordable Care Act-related insurance expansion on trauma care reimbursementJohn W Scott, Pooja U Neiman, Peter A Najjar, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 12, 2001
Hepatic xenobiotic metabolism of cylindrospermopsin in vivo in the mouseR L G Norris, A A Seawright, G R Shaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group projectC L Vogel, R V Smalley, M Raney, et al.
Pageof 65